(Q37750599)

22 August 2017

3 references

25 April 2019

7 November 2019

20 November 2019

New acute treatments for headache (English)

1 reference

22 August 2017

1 reference

7 November 2019

2 references

7 November 2019

20 November 2019

1 reference

20 November 2019

1 reference

Alan M Rapoport

1

1 reference

22 August 2017

1 June 2010

4 references

22 August 2017

25 April 2019

7 November 2019

20 November 2019

Neurological Sciences

4 references

22 August 2017

25 April 2019

7 November 2019

20 November 2019

31 Suppl 1

1 reference

22 August 2017

S129-32

1 reference

Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869016

Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869016

New and future migraine therapy

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869016

Calcitonin gene-related peptide does not excite or sensitize meningeal nociceptors: implications for the pathophysiology of migraine

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869016

Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869016

The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats.

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869016

Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869016

Antimigraine drugs: new frontiers

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869016

Safety and pharmacokinetics of dihydroergotamine mesylate administered via a Novel (Tempo) inhaler

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869016

Botulinum toxin type A and divalproex sodium for prophylactic treatment of episodic or chronic migraine

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869016

Aerosol delivery of ergotamine tartrate via a breath-synchronized plume-control inhaler in humans

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869016

CGRP-receptor antagonism in migraine treatment

1 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10072-010-0304-7

10.1007/S10072-010-0304-7

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference

PMC publication ID

2869016

22 August 2017

PubMed publication ID

20464603

1 reference

PMC publication ID

2869016